Roa, Shawn Michael .
HRN: 23-65-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/04/2023
09/10/2023
IVT
265mg
Q6hrs
Pcap C; T/c CHD
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes